The Bisacodyl Delayed Release Tablet, cataloged under National Stock Number 6505-01-603-0287, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is The Harvard Drug Group, L.l.c. Dba the Harvard Drug Group, L.l.c Div Major Pharmaceuticals & Rugby Laboratories. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-603-0287 |
| Primary Part Number | NDC00904-6748-60 |
| Item Name | Bisacodyl Delayed Release Tablet |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | The Harvard Drug Group, L.l.c. Dba the Harvard Drug Group, L.l.c Div Major Pharmaceuticals & Rugby Laboratories |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00904-6748-60 PRIMARY | The Harvard Drug Group, L.l.c. Dba the Harvard Drug Group, L.l.c Div Major Pharmaceuticals & Rugby Laboratories (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM127095 | 5/1 Secondary reference Defense Medical Standardization Board |
| 30336 | 5/1 Secondary reference U.S. Government activity |
| NDC00536-3381-01 | 3/9 Design control — primary reference Watson Pharmaceuticals, Inc. |
NSN 6505-01-603-0287 is a Bisacodyl Delayed Release Tablet, manufactured by The Harvard Drug Group, L.l.c. Dba the Harvard Drug Group, L.l.c Div Major Pharmaceuticals & Rugby Laboratories, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-603-0287 has 1 manufacturer part number on file: NDC00904-6748-60 (The Harvard Drug Group, L.l.c. Dba the Harvard Drug Group, L.l.c Div Major Pharmaceuticals & Rugby Laboratories).
Key specifications for NDC00904-6748-60: Special Features: 5 MG BISACODYL ACTIVE INGREDIENT; ENTERIC COATED; DELAYED RELEASE TABLETS 100 PER BOTTLE.; Part Name Assigned by Controlling Agency: BISACODYL DELAYED RELEASE TABLET 5MG ENTERIC COATED BT 100S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.